Sysmex Corp (6869) - Medical Equipment - Deals and Alliances Profile

Sysmex Corp (6869) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME1016D
  • |
  • Pages: 88
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Sysmex Corp (6869)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Sysmex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Sysmex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Sysmex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Sysmex Corp, Medical Equipment, Deal Details 13

Partnerships 13

Sysmex Enters into Licensing Agreement with Human Metabolome Technologies 13

Sysmex Enters Into Licensing Agreement With Merck Millipore 14

Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio 15

Sysmex, Foundation for Biomedical Research and Kyoto University Enter into Joint Research Agreement 16

JVCKENWOOD to Form Joint Venture with Sysmex 17

genedrive Enters into Distribution Agreement with Sysmex Asia Pacific 18

genedrive Enters into Distribution Agreement with Sysmex Europe 19

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 20

Sysmex Partners with Clearbridge BioMedics 21

Sysmex Inostics Enters into Distribution Agreement with Streck 22

Sysmex America Enters into Distribution Agreement with Medline Industries 23

Eisai Enters into Agreement with Sysmex 24

Sysmex Enters into Co-Development Agreement with LabCorp 25

Sysmex Inostics Enters into Distribution Agreement with IndivuTest 26

Sysmex and Toppan Printing to Collaborate in Genetic Analysis Testing Industry 27

Sysmex America Enters Into Distribution Agreement With Henry Schein For Hematology Analyzers 28

Sysmex America Enters Into Agreement With Software Testing Solutions 29

National Cancer Center Enters into Co-Development Agreement with Sysmex 30

Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare 31

Sysmex America Extends Distribution Agreement With Medica For EasyCell Assistant 32

Endomagnetics Enters Into Distribution Agreement With Sysmex Europe 33

Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 34

Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 35

Sysmex Extends Distribution Agreement With Roche 36

Asset Transactions 37

Windsor Regional Hospital Acquires Sysmex XN-Series Hematology Analyzers From Sysmex Canada 37

Acquisition 38

bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 38

Sysmex Acquires Oxford Gene Technology 39

Sysmex Acquires Partec 40

Sysmex Completes Acquisition of Inostics from Indivumed 41

Sysmex Rumored To Acquire Dune Medical Devices For USD 200 Million 43

Sysmex Corp-Key Competitors 44

Sysmex Corp-Key Employees 45

Sysmex Corp-Locations And Subsidiaries 46

Head Office 46

Other Locations & Subsidiaries 46

Joint Venture 49

Recent Developments 50

Strategy And Business Planning 50

Nov 08, 2018: OGT further expands global direct sales and support into Asia-Pacific 50

Aug 03, 2018: Sysmex and JVCKENWOOD jointly establish company to use micro and nano-fabrication technology to develop and manufacture IVD Biodevices 51

Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 53

May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 54

May 08, 2018: Sysmex to Establish Bio-Diagnostic Reagent Center 56

Dec 11, 2017: Sysmex to Commence OncoBEAM Lab Assay Services (for Research) in Japan, as well as in Germany and the United States, to Analyze Genetic Mutations Related to Circulating Tumor DNA 57

Jun 01, 2017: Sysmex Opens New RD Facility with a View toward the Realization of Personalized Medicine 59

Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 60

Financial Announcements 61

Aug 03, 2018: Sysmex: Summary of consolidated financial results for the first three months of the fiscal year ending March 31, 2019 61

May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 66

Feb 06, 2018: Sysmex: Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018 69

Corporate Communications 71

Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes 71

Sep 13, 2017: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year 73

Legal and Regulatory 74

Apr 24, 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers 74

Jan 18, 2018: Sysmex Harmony Wins Certification as Special Subsidiary Company 76

Product News 77

Mar 29, 2018: Sysmex to Launch the Automated High-sensitive Immunoassay System for Research Applications HI-1000 77

Oct 12, 2017: Sysmex: Insurance Coverage of Lymph Node Metastasis Testing for Non-Small-Cell Lung Cancer Using the OSNA Method 78

Sep 26, 2017: Sysmex Launches the Revohem FVIII Chromogenic, a Coagulation Factor VIII Assay Reagent 79

Other Significant Developments 80

Jul 02, 2018: OGT expands direct sales and support infrastructure in Europe 80

Apr 05, 2018: Sysmex Launches Caresphere a New Network Solution 81

Apr 04, 2018: Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors 83

Sep 19, 2017: Sysmex Signs Agreement with Mongolia's Ministry of Health to Provide External Quality Assessment Support in the Field of Blood Morphology Testing 84

Sep 05, 2017: Sysmex Begins Conducting Direct Sales and Services in Ghana 86

May 21, 2017: Sysmex New Zealand Commence Direct Sales of Urinalysis Instrument Portfolio 87

Appendix 88

Methodology 88

About GlobalData 88

Contact Us 88

Disclaimer 88

List of Figures

Sysmex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sysmex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Sysmex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Sysmex Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

List of Tables

Sysmex Corp, Medical Equipment, Key Facts, 2018 2

Sysmex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sysmex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Sysmex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Sysmex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Sysmex Corp, Deals By Market, 2012 to YTD 2018 10

Sysmex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Sysmex Enters into Licensing Agreement with Human Metabolome Technologies 13

Sysmex Enters Into Licensing Agreement With Merck Millipore 14

Roche Enters Into Licensing Agreement With Sysmex Inostics For emPCR Patent Portfolio 15

Sysmex, Foundation for Biomedical Research and Kyoto University Enter into Joint Research Agreement 16

JVCKENWOOD to Form Joint Venture with Sysmex 17

genedrive Enters into Distribution Agreement with Sysmex Asia Pacific 18

genedrive Enters into Distribution Agreement with Sysmex Europe 19

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 20

Sysmex Partners with Clearbridge BioMedics 21

Sysmex Inostics Enters into Distribution Agreement with Streck 22

Sysmex America Enters into Distribution Agreement with Medline Industries 23

Eisai Enters into Agreement with Sysmex 24

Sysmex Enters into Co-Development Agreement with LabCorp 25

Sysmex Inostics Enters into Distribution Agreement with IndivuTest 26

Sysmex and Toppan Printing to Collaborate in Genetic Analysis Testing Industry 27

Sysmex America Enters Into Distribution Agreement With Henry Schein For Hematology Analyzers 28

Sysmex America Enters Into Agreement With Software Testing Solutions 29

National Cancer Center Enters into Co-Development Agreement with Sysmex 30

Sysmex Inostics Enters Into Co-Development Agreement With Bayer HealthCare 31

Sysmex America Extends Distribution Agreement With Medica For EasyCell Assistant 32

Endomagnetics Enters Into Distribution Agreement With Sysmex Europe 33

Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 34

Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 35

Sysmex Extends Distribution Agreement With Roche 36

Windsor Regional Hospital Acquires Sysmex XN-Series Hematology Analyzers From Sysmex Canada 37

bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 38

Sysmex Acquires Oxford Gene Technology 39

Sysmex Acquires Partec 40

Sysmex Completes Acquisition of Inostics from Indivumed 41

Sysmex Rumored To Acquire Dune Medical Devices For USD 200 Million 43

Sysmex Corp, Key Competitors 44

Sysmex Corp, Key Employees 45

Sysmex Corp, Other Locations 46

Sysmex Corp, Subsidiaries 47

Sysmex Corp, Joint Venture 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sysmex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17840
Site License
USD 500 INR 35680
Corporate User License
USD 750 INR 53520

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com